DMD and Duchenne muscular dystrophy: Although several approaches, including micro‐dystrophin gene therapy and treatment with exon skipping‐inducing antisense oligonucleotides, have been approved or are currently under approval [6, 7, 8], glucocorticoids remain the gold standard treatment for all DMD patients, with proven potential to slow disease progression [9].